KeyBanc Maintains a 'Buy' on Lubrizol (LZ); Raises Price target & Estimates
More News related to LZ
- Lubrizol (NYSE: LZ) Posts Q3 EPS of $2.46, Misses Estimates by 6c; Guides FY09 EPS
- Lubrizol Announces Third Quarter 2009 Earnings and Increases Full-Year Earnings Guidance
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
- After-Hours Movers 10/21: SDXC, FFIV, HNI, COHU, GGG, SKX, LHO Higher; AFFX, NVEC, TEX, ADS, EBAY, EQIX Lower
- Lubrizol (LZ) Sees Q3 Adj-EPS of $2.52
More News related to Analyst Comments
- Keynote Systems (KEYN) Initiates $0.05 Quarterly Dividend; 1.9% Yield
- Source Capital (SOR) Declares $0.50 Quarterly Dividend; 4.8% Yield
- Healthcare Realty Trust (HR) Declares $0.385 Quarterly Dividend; 7.3% Yield
- Massey Energy (MEE) Declares $0.06 Quarterly Dividend; 0.7% Yield
- RadioShack Corp (RSH) Declare $0.25 Quarterly Dividend; 4.9% Yield
KeyBanc maintains a 'Buy' on Lubrizol Corporation (NYSE: LZ), raises price target from $53 to $64.
KeyBanc analyst says, "We sense that the momentum continues to grow for Lubrizol (LZ-NYSE) in 2Q09 and will likely be carried over into 2H09 as well; we expect that 2H09 earnings will be stronger than 1H09. Our increased confidence in 2009 is driven by our belief that the price/cost benefit remains favorable in Lubricant Additives and that operational improvements in Advanced Materials are tracking ahead of our previous expectations...As a result of our increased confidence, we are raising our 2Q09 EPS estimate to $1.35 (was $1.30; consensus is $1.20) vs. $1.26 in 2Q08; our 2009 and 2010 EPS estimates now stand at $4.50 (was $4.35; current guidance is $3.95-$4.35; consensus is $4.22) and $4.85 (was $4.75), respectively."
To see more analyst ratings on LZ Click Here.
The Lubrizol Corporation (Lubrizol) is a specialty chemical company that produces and supplies technologies for the global transportation, industrial and consumer markets.
Related Categories
Analyst CommentsStocks Mentioned
+0.00Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
